There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for CYBN is 18.62M, and at present, short sellers hold a 5.61% of that float. The average trading volume of CYBN on July 03, 2025 was 316.98K shares.
CYBN) stock’s latest price update
Cybin Inc (AMEX: CYBN)’s stock price has decreased by -18.00% compared to its previous closing price of $9.0. However, the company has seen a -10.65% decrease in its stock price over the last five trading sessions. businesswire.com reported 2025-07-01 that TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American: CYBN) (Cboe Canada: CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce the Company has entered into a securities purchase agreement (the “Securities Purchase Agreement”) with High Trail Special Situations LLC (“High Trail”), pursuant to which the Company agreed to sell a.
CYBN’s Market Performance
CYBN’s stock has fallen by -10.65% in the past week, with a monthly drop of -8.89% and a quarterly rise of 24.87%. The volatility ratio for the week is 11.26% while the volatility levels for the last 30 days are 8.07% for Cybin Inc The simple moving average for the past 20 days is -11.01% for CYBN’s stock, with a -15.34% simple moving average for the past 200 days.
Analysts’ Opinion of CYBN
Many brokerage firms have already submitted their reports for CYBN stocks, with Guggenheim repeating the rating for CYBN by listing it as a “Buy.” The predicted price for CYBN in the upcoming period, according to Guggenheim is $35 based on the research report published on March 13, 2025 of the current year 2025.
CYBN Trading at -2.35% from the 50-Day Moving Average
After a stumble in the market that brought CYBN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -46.83% of loss for the given period.
Stock Fundamentals for CYBN
The total capital return value is set at -0.45. Equity return is now at value -42.90, with -40.52 for asset returns.
Currently, EBITDA for the company is -78.58 million with net debt to EBITDA at 1.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.75.
Conclusion
In summary, Cybin Inc (CYBN) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
